Search

everythinglearnresearchcommunity

for

Search:↓

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

The document's conclusion cannot be provided because the content is not accessible.

Low iron levels are linked to hair loss in adult women.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

People with chronic hair shedding have lower antioxidant levels in their blood compared to healthy individuals.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

A rare skin condition causes red and dark patches on the face and limbs.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Vitamin D levels are not correlated with chronic hair loss in Telogen Effluvium patients.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

Gloriosa superba poisoning can cause sudden hair loss, but hair usually regrows fully.

Extreme weight loss from crash dieting can cause significant hair loss.

COVID-19 increased hair loss cases, but vaccination did not.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.

More grafts and longer surgeries increase the risk of hair loss in the donor area after FUE hair transplants.

Postpartum hair loss is common, temporary, and linked to hormonal changes, stress, and nutrition.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

A woman had temporary hair loss due to stress from a spinal cord injury.

Hair loss might be an early sign of Hodgkin disease.

A woman experienced fluctuating thyroid conditions and eye disease, but her symptoms improved with treatment.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.